Navigation Links
BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results
Date:4/29/2009

through economic uncertainty. Our balance sheet and liquidity positions remain very strong, thanks to our ongoing efforts to proactively manage our capital structure. The refinancing of our joint venture's secured acquisition and interim loan is especially noteworthy as it extended the maturity by two years, with an option for an additional year, and demonstrated the support and commitment of our lending partners in an otherwise highly restrictive credit market. And, we are making solid progress on refinancing our upcoming loan maturities, including securing permanent financing for our Center for Life Science | Boston asset."

Portfolio Update

During the quarter ended March 31, 2009, the company executed 13 leasing transactions representing approximately 420,000 square feet, including nine new leases totaling approximately 121,000 square feet and four leases amended to extend their terms totaling approximately 299,000 square feet.

As of March 31, 2009, BioMed owned or had interests in 69 properties with 112 buildings, located predominantly in the major U.S. life science markets of Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania and New York/New Jersey. The company's portfolio included the following as of March 31, 2009:

                                                      Rentable
                                                     Square Feet
                                                     -----------
    Operating portfolio                               8,233,988
    Repositioning and redevelopment properties        1,543,858
    Construction in progress                            736,708
                                                     ----------
      Total portfolio                                10,514,554
                                                     ----------

    Land parcels                                      1,352,000
  
'/>"/>
SOURCE  BioMed Realty Trust, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 

Related medicine news :

1. Dr. Abbott J. Krieger Joins Avery Biomedical Devices, Inc. as Chief Clinical Liaison
2. Bio-Matrix Scientific Group and Entest BioMedical Sign Contract With UCLA Researcher to Develop Gestational Diabetes Screening Test
3. Four legendary LA BioMed physician-researchers honored
4. Sickle cell treatment developed at LA BioMed approved for phase 3 clinical trial
5. Response Biomedical Corporation Delivers Record Preliminary Revenues in First Quarter
6. BioMedical Technology Solutions, Inc. a Division of BioMedical Technology Solutions Holdings, Inc. Symbol (BMTL) OTCBB Receives Frost & Sullivans Product Innovation of the Year Award
7. Foundation for Biomedical Research Announces Michael E. DeBakey Journalism Awards
8. Response Biomedical Corporation Reports 2008 Financial Results
9. Advance Internet Launches HireBioMedical.com
10. Hollow gold nanospheres show promise for biomedical and other applications
11. Foundation for Biomedical Research Releases Groundbreaking PSA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... Lansing, MI (PRWEB) May 20, ... Michigan Lupus Foundation will be ... meeting in Lansing on June ... Monday, June 10th, 6:30 p.m. ... Professional Building (Across from Sparrow ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 Co-founder of ... will be a keynote speaker at the 5th International ... The conference brings together company representatives and independent ... trends in Internet marketing and investments. , The 2013 ... Inn Business Hotel México from May 20 to 21. ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 The ... and community leaders behind bars for good at an ... 22 beginning at 9 a.m. , More than ... Executive Lock-Up to benefit individuals and families affected by ... including city officials, local celebrities, realtors, doctors, attorneys, bankers, ...
(Date:5/20/2013)... May 20, 2013 ... Who:    Sloan Gibson, President, USO and CEO ... of Outreach Initiatives and Partners, Sesame ... , Representatives from:,              ... • U.S. House ...
(Date:5/20/2013)... 20, 2013 National law firm Parker Waichman ... Law Firm P.A., both based in Little Rock, Arkansas – ... proposed $7.25 billion settlement of a price-fixing case against Visa ... was filed Wednesday, May 15, 2013, in the U.S. District ... lawsuit against Visa and MasterCard (Case No. 1:05-md-1720) is titled ...
Breaking Medicine News(10 mins):Health News:EverSpark CEO to be Keynote Speaker at 5th International INVEST Domaining & Internet Marketing Conference in Mexico City 2Health News:MDA to Put Fort Lauderdale Community Leaders Behind Bars for Good 2Health News:USO to Celebrate Five-Year Partnership of Sesame Street/USO Experience for Military Families at Biannual Care Package Service Project on Capitol Hill 2Health News:USO to Celebrate Five-Year Partnership of Sesame Street/USO Experience for Military Families at Biannual Care Package Service Project on Capitol Hill 3Health News:USO to Celebrate Five-Year Partnership of Sesame Street/USO Experience for Military Families at Biannual Care Package Service Project on Capitol Hill 4Health News:Parker Waichman LLP Takes on the Credit Card Companies, Fights for Smaller Retailers that Form the U.S. Economy’s ‘Backbone’ 2Health News:Parker Waichman LLP Takes on the Credit Card Companies, Fights for Smaller Retailers that Form the U.S. Economy’s ‘Backbone’ 3
... in the open access journal BMC Medicine has found that ... people in India are flawed and the actual number of ... who are from the Administrative Staff College of India, conducted ... of Medical Sciences in Hyderabad. ,According to ...
... to be merry, for Christmas is fast approaching. The Santa ... celebration, spreading cheer// all around, are observed to be grossly ... ,Doctors in Scotland have explained how most of the ... frightfully fat, and need to diet on a war footing. ...
... spiritual leader Sri Sri Ravi Shankar will set up ... an "amalgamation of science and spirituality". ,Yezdi Batliwala ... Trust, the educational wing of the Art of Living ... Tripathy, the secretary of the state's higher education department, ...
... from Quebec had a man made heart implanted inside ... who does not have a heart beat! ,“Heartmate II”, ... Cecere and Dr Nadia Giannetti in a three-hour surgery on Nov. ... decade. It works using a turbine balanced within a magnetic field. ...
... most often end up selling their homes according to a ... ,People diagnosed with cancer experience loss of income, ... at the same time face a number of extra costs, ... ,The Macmillan Cancer Support research indicated that almost 20% ...
... problems are not protected from attacks or stroke by taking ... ,Folic acid or folate is one of the B ... Some medical practitioners prescribe it to prevent cardiac problems. ... Public Health and Tropical Medicine, New Orleans led a research ...
Cached Medicine News:
(Date:5/20/2013)... May 20, 2013  Echo Pharma Acquisition Limited ("Royalty ... Irish Takeover Rules (the "Announcement"), a firm intention to ... ELN ) to $12.50 per share in cash.  ... not conditional on due diligence.  The $1.00 per share ... reserved the right to waive down the Acceptance Threshold ...
(Date:5/20/2013)...  Atlantic Pharmaceuticals, Inc., a specialty pharmaceutical company ... technology to deter prescription drug abuse today announced ... Soscia , has been chosen as a ... Health-Care Heroes Awards. The awards are presented annually ... individuals and organizations demonstrating excellence and deserving recognition ...
(Date:5/20/2013)... -- Rhythm announced today the presentation of results from a ... symptoms among diabetic patients in the U.S. than previously ... with both type 1 and type 2 diabetes, but ... more common type 2 disease. ... of Medicine at Harvard Medical School and Director of ...
Breaking Medicine Technology:Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 2Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 3Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 4Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 5Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 6Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 7Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 8Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 9Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 10Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 11Atlantic Pharmaceuticals President Named Health Care Hero Finalist in Atlanta Business Chronicle for Drug Abuse Deterrent Technology 2Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S. 2Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S. 3Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S. 4
... This May, Joao Pedras-Vasconcelos, Visiting Associate, Therapeutic ... European industry experts at Pharma IQ,s to discuss FDA ... Over the last two years, the regulations have been ... there has been some confusion within the industry as ...
... 2011 Morphotek®, Inc., a subsidiary of Eisai ... assets relating to a proprietary tumor targeting platform ... payment and future development milestones. TMI, a biotechnology ... the tumor-targeting peptide (TTP) platform capable of delivering ...
Cached Medicine Technology:FDA to Address Industry Questions About Biosimilar Regulations at the Pharma's IQ Immunogenicity Event 2Morphotek®, Inc. Announces Acquisition of Tumor Targeting Assets From Transmolecular, Inc. 2Morphotek®, Inc. Announces Acquisition of Tumor Targeting Assets From Transmolecular, Inc. 3
XL STABI Hydrophilic Acrylic Lens....
XL OCTO Hydrophilic Acrylic Lens....
One piece multifocal acrylic intraocular lens....
MemoryLens Prefolded Acrylic Lens....
Medicine Products: